Log In Get Started
Press Releases August 31, 2026 04:01 PM

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14

Kestra Medical Technologies to announce Q1 fiscal 2027 financial results on September 14

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
KMTS

Kestra Medical Technologies, a wearable medical device and digital healthcare company, will report its first quarter fiscal 2027 financial results after market close on September 14, followed by a management conference call.

Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14
KMTS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Kestra Medical Technologies focuses on cardiovascular disease through wearable monitoring and therapeutic technologies.
  • The company’s financial results for the first quarter of fiscal 2027 will be released on September 14.
  • A conference call and webcast will be available for investors and analysts to discuss results.

KIRKLAND, Wash., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report first quarter fiscal 2027 financial results after the market closes on Monday, September 14.

Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website.

About Kestra
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.


Risks

  • Financial performance unknown until results are announced, which may lead to market uncertainty.
  • Dependence on successful adoption of wearable medical devices and digital health technologies.
  • Risks related to competitive pressures in the medical device and digital healthcare sectors.

More from Press Releases

Willis appoints Trevor Madden as Head of Captive and Insurance Management Solutions, Asia Pacific Sep 6, 2026 Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026